Weiss Multi Strategy Advisers LLC Gilead Sciences, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $6.78 Million - $7.73 Million	-87,748 Reduced 74.96%	29,304 $2.43 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $407,136 - $584,507	6,533 Added 5.91%	117,052 $10 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $3.2 Million - $3.66 Million	53,813 Added 94.9%	110,519 $6.82 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $3.27 Million - $3.69 Million	56,706 New	56,706 $3.51 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.25 Million - $1.6 Million	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $308,100 - $338,900	5,000 Added 33.33%	20,000 $1.3 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $437,570 - $483,000	7,000 Added 87.5%	15,000 $951,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $570,240 - $631,360	8,000 New	8,000 $618,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $3.56 Million - $4.18 Million	-50,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.61 Million - $4.27 Million	50,000	50,000 $4.05 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.